Leaf Hydroalcoholic Extract and Oleoresin from Control Infection in Human Trophoblast Cells and Placental Explants from Third-trimester Pregnancy

The conventional treatment of congenital toxoplasmosis is mainly based on the combination of sulfadiazine and pyrimethamine. However, therapy with these drugs is associated with severe side effects and resistance, requiring the study of new therapeutic strategies. There are currently many studies with natural products, including oleoresin, showing actions against some pathogens, as and . In the present study, we investigated the effects of the leaf hydroalcoholic extract and oleoresin from against in human villous (BeWo) and extravillous (HTR8/SVneo) trophoblast cells, as well as in human villous explants from third-trimester pregnancy. For this purpose, both cells and villous explants were infected or not with , treated with hydroalcoholic extract or oleoresin from and analyzed for toxicity, parasite proliferation, cytokine and ROS production. In parallel, both cells were infected by tachyzoites pretreated with hydroalcoholic extract or oleoresin, and adhesion, invasion and replication of the parasite were observed. Our results showed that the extract and oleoresin did not trigger toxicity in small concentrations and were able to reduce the intracellular proliferation in cells previously infected. Also, the hydroalcoholic extract and oleoresin demonstrated an irreversible antiparasitic action in BeWo and HTR8/SVneo cells. Next, adhesion, invasion and replication of were dampened when BeWo or HTR8/SVneo cells were infected with pretreated tachyzoites. Finally, infected and treated BeWo cells upregulated IL-6 and downmodulated IL-8, while HTR8/SVneo cells did not change significantly these cytokines when infected and treated. Finally, both the extract and oleoresin reduced the proliferation in human explants, and no significant changes were observed in relation to cytokine production. Thus, compounds from presented different antiparasitic activities that were dependent on the experimental model, being the direct action on tachyzoites a common mechanism operating in both cells and villi. Considering all these parameters, the hydroalcoholic extract and oleoresin from can be a target for the establishment of new therapeutic strategy for congenital toxoplasmosis.

Citing Articles

Galectin-3 plays a key role in controlling infection by in human trophoblast cells and human villous explants.

Luz L, Ribeiro M, Teixeira S, de Souza G, Paschoalino M, Sousa D Front Cell Infect Microbiol. 2024; 14:1459810.

PMID: 39654979 PMC: 11625798. DOI: 10.3389/fcimb.2024.1459810.

The Search for Drugs Derived from Natural Products for Infection Treatment in the Last 20 Years - A Systematic Review.

Marques-Santos F, Xavier Faria R, Amendoeira M Curr Top Med Chem. 2024; 24(22):1960-1999.

PMID: 38952156 DOI: 10.2174/0115680266299409240606062235.

P21 recombinant protein modulates infection in different experimental models of the human maternal-fetal interface.

de Souza G, Teixeira S, Fajardo Martinez A, Silva R, Luz L, de Lima Junior J Front Immunol. 2023; 14:1243480.

PMID: 37915581 PMC: 10617204. DOI: 10.3389/fimmu.2023.1243480.

References

Halonen S, Weiss L . Toxoplasmosis. Handb Clin Neurol. 2013; 114:125-45. PMC: 4157368. DOI: 10.1016/B978-0-444-53490-3.00008-X. View

Ribeiro M, Franco P, Lopes-Maria J, Angeloni M, de Freitas Barbosa B, de Oliveira Gomes A . Azithromycin treatment is able to control the infection by two genotypes of Toxoplasma gondii in human trophoblast BeWo cells. Exp Parasitol. 2017; 181:111-118. DOI: 10.1016/j.exppara.2017.08.004. View

da Silva R, Gomes A, Franco P, Pereira A, Milian I, Ribeiro M . Enrofloxacin and Toltrazuril Are Able to Reduce Growth in Human BeWo Trophoblastic Cells and Villous Explants from Human Third Trimester Pregnancy. Front Cell Infect Microbiol. 2017; 7:340. PMC: 5526852. DOI: 10.3389/fcimb.2017.00340. View

Castro A, Alves C, Angeloni M, Gomes A, Barbosa B, Franco P . Trophoblast cells are able to regulate monocyte activity to control Toxoplasma gondii infection. Placenta. 2013; 34(3):240-7. DOI: 10.1016/j.placenta.2012.12.006. View

de Souza G, Silva R, Milian I, Rosini A, de Araujo T, Teixeira S . Cyclooxygenase (COX)-2 modulates Toxoplasma gondii infection, immune response and lipid droplets formation in human trophoblast cells and villous explants. Sci Rep. 2021; 11(1):12709. PMC: 8209052. DOI: 10.1038/s41598-021-92120-3. View

Santos A, Costa M, Ueda-Nakamura T, Dias-Filho B, Veiga-Junior V, De Souza Lima M . Leishmania amazonensis: effects of oral treatment with copaiba oil in mice. Exp Parasitol. 2011; 129(2):145-51. DOI: 10.1016/j.exppara.2011.06.016. View

Fitch W, MacKenzie E, Harper A . Effects of decreasing arterial blood pressure on cerebral blood flow in the baboon. Influence of the sympathetic nervous system. Circ Res. 1975; 37(5):550-7. DOI: 10.1161/01.res.37.5.550. View

Barbosa B, Lopes-Maria J, Gomes A, Angeloni M, Castro A, Franco P . IL10, TGF beta1, and IFN gamma modulate intracellular signaling pathways and cytokine production to control Toxoplasma gondii infection in BeWo trophoblast cells. Biol Reprod. 2015; 92(3):82. DOI: 10.1095/biolreprod.114.124115. View

Rosini A, Teixeira S, Milian I, Silva R, de Souza G, Luz L . LPS-mediated activation of TLR4 controls Toxoplasma gondii growth in human trophoblast cell (BeWo) and human villous explants in a dependent-manner of TRIF, MyD88, NF-κB and cytokines. Tissue Cell. 2022; 78:101907. DOI: 10.1016/j.tice.2022.101907. View

10.

Dhorm Pimentel de Moraes A, Tavares G, Rocha F, de Paula E, Giorgio S . Effects of nanoemulsions prepared with essential oils of copaiba- and andiroba against Leishmania infantum and Leishmania amazonensis infections. Exp Parasitol. 2018; 187:12-21. DOI: 10.1016/j.exppara.2018.03.005. View

11.

Arruda C, Mejia J, Pena Ribeiro V, Gambeta Borges C, Martins C, Sola Veneziani R . Occurrence, chemical composition, biological activities and analytical methods on Copaifera genus-A review. Biomed Pharmacother. 2018; 109:1-20. DOI: 10.1016/j.biopha.2018.10.030. View

12.

Elsheikha H . Congenital toxoplasmosis: priorities for further health promotion action. Public Health. 2007; 122(4):335-53. DOI: 10.1016/j.puhe.2007.08.009. View

13.

Blader I, Coleman B, Chen C, Gubbels M . Lytic Cycle of Toxoplasma gondii: 15 Years Later. Annu Rev Microbiol. 2015; 69:463-85. PMC: 4659696. DOI: 10.1146/annurev-micro-091014-104100. View

14.

Gomes A, Barbosa B, Franco P, Ribeiro M, Silva R, Gois P . Macrophage Migration Inhibitory Factor (MIF) Prevents Maternal Death, but Contributes to Poor Fetal Outcome During Congenital Toxoplasmosis. Front Microbiol. 2018; 9:906. PMC: 5952001. DOI: 10.3389/fmicb.2018.00906. View

15.

Zhang Y, Lai B, Juhas M, Zhang Y . Toxoplasma gondii secretory proteins and their role in invasion and pathogenesis. Microbiol Res. 2019; 227:126293. DOI: 10.1016/j.micres.2019.06.003. View

16.

Miranda N, Araujo E, Justino A, Cariaco Y, Mota C, Costa-Nascimento L . Anti-parasitic activity of Annona muricata L. leaf ethanolic extract and its fractions against Toxoplasma gondii in vitro and in vivo. J Ethnopharmacol. 2021; 273:114019. DOI: 10.1016/j.jep.2021.114019. View

17.

Lazarin-Bidoia D, Garcia F, Ueda-Nakamura T, de Oliveira Silva S, Nakamura C . Natural compounds based chemotherapeutic against Chagas disease and leishmaniasis: mitochondrion as a strategic target. Mem Inst Oswaldo Cruz. 2022; 117:e220396. PMC: 8970591. DOI: 10.1590/0074-02760220396. View

18.

da Silva Moraes T, Leandro L, Santiago M, de Oliveira Silva L, Bianchi T, Sola Veneziani R . Assessment of the antibacterial, antivirulence, and action mechanism of Copaifera pubiflora oleoresin and isolated compounds against oral bacteria. Biomed Pharmacother. 2020; 129:110467. DOI: 10.1016/j.biopha.2020.110467. View

19.

Souza A, Martins C, Souza M, Furtado N, Heleno V, de Sousa J . Antimicrobial activity of terpenoids from Copaifera langsdorffii Desf. against cariogenic bacteria. Phytother Res. 2010; 25(2):215-20. DOI: 10.1002/ptr.3244. View

20.

FOWLER N, McCall D, Chou T, Holmes J, HANENSON I . Electrocardiographic changes and cardiac arrhythmias in patients receiving psychotropic drugs. Am J Cardiol. 1976; 37(2):223-30. DOI: 10.1016/0002-9149(76)90316-7. View